Latest Developments in the Treatment of Pulmonary Arterial Hypertension
Guest: Robert P. Frantz, M.D.
Host: Kyle Klarich, M.D.
Overview:
Pulmonary arterial hypertension (PAH) is a serious disease manifested by vasoconstriction and obliteration of the pulmonary arterial vasculature resulting in rise in pulmonary artery pressure and resistance and culminating in right heart failure. Listeners will learn more about traditional treatments for PAH, as well as new anti-proliferative therapies in active clinical investigation, and what that means for the future of treatment.
Topics Discussed:
• What is most new and exciting in the treatment of pulmonary arterial hypertension?
• What monitoring is necessary in order to safely use sotatercept?
• What future developments do you envision for the field of pulmonary hypertension?
Length: 00:00:00